Application of ALOGPS 2.1 to predict log D distribution coefficient for pfizer proprietary compounds

Journal of Medicinal Chemistry

Volumn 47, Issue 23, 2004, Pages 5601-5604

  Tetko, Igor V ^a,c   Poda, Gennadiy I ^b  

^a INSTITUTE OF BIOORGANIC CHEMISTRY AND PETROCHEMISTRY   (Ukraine)

^b PFIZER INC   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTANOL; WATER;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOINFORMATICS; COMPUTER PREDICTION; COMPUTER PROGRAM; DATA ANALYSIS; DATA BASE; DRUG SCREENING; INFORMATION PROCESSING; LIPOPHILICITY; PARTITION COEFFICIENT; PH;

1-OCTANOL; ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DATABASES, FACTUAL; DRUG DESIGN; DRUG INDUSTRY; HYDROGEN-ION CONCENTRATION; NEURAL NETWORKS (COMPUTER); PHARMACEUTICAL PREPARATIONS; PRIVATE SECTOR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE; SOLUBILITY; WATER;

EID: 7444258512     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049509l     Document Type: Article

References (36)

1. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 2001, 46, 3-26.
2. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernas, H.; Karlen, A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 1998, 41, 4939-4949.
3. Liu, X.; Tu, M.; Kelly, R. S.; Chen, C.; Smith, B. J. Development of a computational approach to predict blood-brain barrier permeability. Drug Metab. Dispos. 2004, 32, 132-139.
4. Colmenarejo, G. In silico prediction of drug-binding strengths to human serum albumin. Med. Res. Rev. 2003, 23, 275-301.
5. Ishigami, M.; Honda, T.; Takasaki, W.; Ikeda, T.; Komai, T.; Ito, K.; Sugiyama, Y. A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro. Drug Metab. Dispos. 2001, 29, 282-288.
6. Poulin, P.; Theil, F. P. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J. Pharm. Sci. 2002, 91, 129-156.
7. Lombarde, F.; Obach, R. S.; Shalaeva, M. Y.; Gao, F. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. J. Med. Chem. 2004, 47, 1242-1250.
8. Kerns, E. H. High throughput physicochemical profiling for drug discovery. J. Pharm. Sci. 2001, 90, 1838-1858.
9. Tetko, I. V. The WWW as a tool to obtain molecular parameters. Mini-Rev. Med. Chem. 2003, 3, 809-820.
10. Mannhold, R.; van de Waterbeemd, H. Substructure and whole molecule approaches for calculating log P. J. Comput.-Aided. Mol. Des. 2001, 15, 337-354.
11. Japertas, P.; Didziapetris, R.; Petrauskas, A. Fragmental methods in the analysis of biological activities of diverse compound sets. Mini-Rev. Med. Chem. 2003, 3, 797-808.
12. Livingstone, D. J. Theoretical property predictions. Curr. Top. Med. Chem. 2003, 3, 1171-1192.
13. Livingstone, D. J.; Ford, M. G.; Huuskonen, J. J.; Salt, D. W. Simultaneous prediction of aqueous solubility and octanol/water partition coefficient based on descriptors derived from molecular structure. J. Comput.-Aided. Mol. Des. 2001, 15, 741-752.
14. Huuskonen, J. J.; Livingstone, D. J.; Tetko, I. V. Neural network modeling for estimation of partition coefficient based on atom-type electrotopological state indices. J. Chem. Inf. Comput. Sci. 2000, 40, 947-955.
15. Huuskonen, J. J.; Villa, A. E. P.; Tetko, I. V. Prediction of partition coefficient based on atom-type electrotopological state indices. J. Pharm. Sci. 1999, 88, 229-233.
16. Hansch, C.; Leo, A. J. Subsistent Constants for Correlation Analysis in Chemistry and Biology; Wiley: New York, 1979.
17. Lombardo, F.; Shalaeva, M. Y.; Bissett, B. D.; Chistokhodova, N. ElogD(7.4) 20,000 Compounds Later: Refinements, Observations and Applications. In LogP2004, The 3rd Lipophilicity Symposium; ETH: Zurich, Switzerland, 2004; p L-22.
18. Tetko, I. V.; Tanchuk, V. Y.; Villa, A. E. Prediction of n-octanol/ water partition coefficients from PHYSPROP database using artificial neural networks and E-state indices. J. Chem. Inf. Comput. Sci. 2001, 41, 1407-1421.
19. Tetko, I. V.; Tanchuk, V. Y. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inf. Comput. Sci. 2002, 42, 1136-1145.
20. ALOGPS is available free on-line at http://www.vcclab.org.
21. Tetko, I. V. Neural network studies. 4. Introduction to associative neural networks. J. Chem. Inf. Comput. Sci. 2002, 42, 717-728.
22. Tetko, I. V. Associative neural network. Neural Proc. Lett. 2002, 16, 187-199.
23. Tetko, I. V.; Tanchuk, V. Y.; Poda, G. I. Evaluation of ALOGPS 2.1 on Pfizer Datasets. In LogP2004, The 3rd Lipophilicity Symposium; ETH: Zurich, Switzerland, 2004; p C-30.
24. Tetko, I. V.; Bruneau, P. Evaluation of ALOGPS 2.1 in Astra-Zeneca. In LogP2004, The 3rd Lipophilicity Symposium; ETH: Zurich, Switzerland, 2004; p C-17.
25. Tetko, I. V.; Bruneau, P. Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP and logD, of AstraZeneca in-house database. J. Pharm. Sci., in press.
26. Lombardo, F.; Shalaeva, M. Y.; Tupper, K. A.; Gao, F.; Abraham, M. H. ElogPoct: a tool for lipophilicity determination in drug discovery. J. Med. Chem. 2000, 43, 2922-2928.
27. Lombardo, F.; Shalaeva, M. Y.; Tupper, K. A.; Gao, F. ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. J. Med. Chem. 2001, 44, 2490-2497.
28. ACD Labs suite is available at http://www.acdlabs.com.
29. Tsantili-Kakoulidou, A.; Panderi, I.; Csizmadia, F.; Darvas, F. Prediction of distribution coefficient from structure. 2. Validation of Prolog D, an expert system. J. Pharm. Sci. 1997, 86, 1173-1179.
30. Kier, L. B.; Hall, L. H. Molecular Structure Description: The Electrotopological State; Academic Press: London, 1999; p 245.
31. Hall, L. H.; Kier, L. B. Electrotopological state indices for atom types-a novel combination of electronic, topological, and valence state information. J. Chem. Inf. Comput. Sci. 1995, 35, 1039-1045.
32. The Physical Properties Database (PHYSPROP) is a trademark of Syracuse Research Corporation, www.syrres.com.
33. Oprea, T. I. Current trends in lead discovery: are we looking for the appropriate properties? J. Comput.-Aided. Mol. Des. 2002, 16, 325-334.
34. Oprea, T. I. Property distribution of drug-related chemical databases. J. Comput.-Aided. Mol. Des. 2000, 14, 251-264.
35. Goodnow, R. A.; Gillespie, P.; Bleicher, K. Chemoinformatic tools for library design and the hit-to-lead process: A user's perspective. Cheminformatics in Drug Discovery; Wiley-VCH: Weinheim, Germany, 2005.
36. Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. Estimation of aqueous solubility of chemical compounds using E-state indices. J. Chem. Inf. Comput. Sci. 2001, 41, 1488-1493.